Dermaxime anti-aging skin care cosmetics cellumend anti cellulite cream dermaxime problem and acne skin care products
most advanced anti-aging skin care to fight signs of aging

caucheteux approved quality              

 

 

member of the CTFA


HOME
Contact us
 
ORDERING  
Orders in
USA + the world

:: Worldwide shipping
:: €,£,¥ etc converter
 
INTERNET SECURITY  
Orders in
South Africa

:: Aflewering | Delivery
 
   
FREE INFORMATION

:: Anti-Aging
:: Skin facts
:: Looking your best
:: Problem and acne skin
:: Cosmetic surgery
:: Getting rid of cellulite
:: Guaranteed quality
:: Search our site
:: Formulas
:: Cosmetic ingredients
:: Privacy
:: Copyright
:: Links
 

 

Serilesine® - stimulation of fibroblast creation

Different clinical tests were done to prove that Serilesine helps to keep skin aging at bay by stimulating various mechanisms.

This page looks at how it helps to stimulate the formation of fibroblast in the skin.

To place this in context with how it helps to fight aging and to have a younger looking skin, please look at the Serilesine summary page by clicking here.

stimulation of fibroblast creation

Serilesine is used in the following products:

In vitro fibroblast proliferation

Cell viability is evaluated through an MTT assay. The key component is 3-[4,5dimethylthiazol- 2-yl]-2,5-diphenyl tetrazolium bromide or MTT, which is yellowish in solution.

Mitochondrial dehydrogenases of viable cells cleave its tetrazolium ring, leading to the formation of purple crystals which are insoluble in aqueous solution.

The crystals are re-dissolved in acidified isopropanol and the color in the resulting purple solution is quantified spectrophotometrically.

An increase or decrease in cell number results in a proportional change in the amount of formazan formed, indicating the degree of inhibiting or stimulating cell growth.

Trypsinised fibroblast from human skin are incubated for 48 hours in microplates with SERILESINE® (0.05 mg/ml), Minimal Essential Medium-Na-Piruvate and 5% Fetal calf Serum (FCS).

After the incubation with the tested substance and after medium substitution with fresh medium and MTT, cells are incubated for 3 hours at 37 ºC. Then cells are washed to eliminate MTT excess. The fluorimeter reading is performed at 540 nm wavelength.

A culture of fibroblasts was treated with 0.05 mg/ml SERILESINE® and results were measured after 48 hours. Results are given as optical density (O.D.), that is proportional to cell number:

younger looking skin
After 48 hours an increase of 74.6% was noted in fibroblast proliferation.
fibroblast healthy skin

Due to the fact that combining all the images on one page makes it too large to download within a fair period of time, we created different pages dealing with each aspect that was tested.

The other test that were performed can be viewed by clicking the hyperlink.

If you are looking for the summary page of Serilesine please click here.

fibroblast younger looking skin

Other cosmetic ingredients

Dermaxime products

pci dss compliant
website and shopping security

sallamander concepts
Ageless herbal products
Dermaxime anti-aging skin care
Esoteric essential oils
Cellumend anti-cellulite cream
Sanitoets home test kits and testing strips
Zest for Life vitamin supplements
Instant Eye Lift - eye lift in a bottle
Olinat pure natural facial moisturizing cream
Creme de Vie anti-wrinkle cream

 

Statements made on the products, ingredients and general information have not been evaluated by the FDA and should not be seen as health claims. All ingredients used in our products are safe and are in no way banned, controlled or restricted.
All products are manufactured following strict GMP and ISO standards.

home | products | formulations | ordering | shipping | links to other websites
contact us | search | free information | South African Orders

© Copyright Dermaxime (Pty) Ltd 2001 - 2011.

The entire content of this website is copyrighted - including text, photographs, logos, metatags etc., and no part whatsoever may be copied and used - privately, for educational purposes or publishing or for commercial application - without the written permission of Dermaxime (Pty) Ltd.

Our site was last updated on 4th November 2011.